NZX-listed medical cannabis firm Cannasouth’s classification as a going concern relies on a successful capital raise later this year, but the company is confident it will continue to see market support.
Cannasouth posted a $3.5 million loss in the year to December 31. It had cash on hand of
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
